Health care company Baxter International, Inc. (BAX) reported Thursday a net loss attributable to shareholders for the fourth quarter of $1.12 billion or $2.19 per share, sharply wider than $512 million or $1.00 per share in the prior-year quarter.
Net loss from continuing operations totaled $1.04 billion or $2.01 per share, compared to net loss of $488 million or $0.95 per share in the year-ago quarter.
Excluding items, adjusted income from continuing operations for the quarter was $0.44 per share, compared to $0.58 per share last year.
On average, 14 analysts polled expected the company to report earnings of $0.54 per share for the quarter. Analysts' estimates typically exclude special items.
Worldwide net sales for the quarter grew 8 percent to $2.97 billion from $2.75 billion in the same quarter last year. It grew only 3 percent on an operational basis. Analysts expected revenues of $2.82 billion for the quarter.
Looking ahead to fiscal 2026, the company now projects adjusted earnings from continuing operations in a range of $1.85 to $2.05 per share on sales growth from continuing operations of flat to 1 percent on a reported basis, with flat organic sales growth from continuing operations.
The Street is looking for earnings of $2.25 per share on a revenue decline of 4.96 percent to $11.31 billion for the year.
In Thursday's pre-market trading, BAX is trading on the NYSE at $19.02, down $3.26 or 14.63 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.